… that compared pemetrexed to docetaxel as second-line treatment… and efficacy of erlotinib
as second and third line treatment in … the efficacy of erlotinib or gefitinib when compared to …

… the efficacy of a treatment, they are insufficient to establish the … (CE) of the third-line erlotinib
protocol, compared to the next-… Lee compared second-line gefitinib (trade name Iressa™, …

… Docetaxel has demonstrated superiority compared with best … to chemotherapy, and in all
patients as third-line treatment after … activity and efficacy of treatment with erlotinib and gefitinib. …

… and efficacy of third-line anlotinib for patients with refractory … erlotinib or gefitinib and have
a PS of 0–3, the efficacy of this … in NSCLC, although direct comparisons of AEs with other …

… the efficacy and safety of erlotinib monotherapy as third-line … of its equivalent efficacy and
lower toxicity compared with … active dose than gefitinib may induce different efficacy in patients …

… Docetaxel, pemetrexed, erlotinib, and gefitinib are … In this paper, we present an NMA
comparing the relative efficacy … including both second- and third-line therapy, because there is no …

… the gefitinib (P=0.008), erlotinib, icotinib, and only OS in gefitinib … the OS times of patients
compared to placebo. However, the … treatments had no impact on the efficacy of anlotinib in …

… We aimed to assess its efficacy in patients with advanced lung adenocarcinoma with … This
study, in the third-line and fourth-line setting, failed to show a difference between groups in its …

… chemotherapy has shown no advantage as compared to single … efficacy of combinations
among chemotherapy and targeted … Erlotinib 150 mg/day is now used as third line treatment of …

… of erlotinib (E) and gefitinib (G) in patients with relapsed NSCLC in both second- and third-line
settings, and compared this … [3] and JMEI [5] studies suggest that efficacy may be similar. …